Laura Green

Laura Green is Professor of Haemostasis and Transfusion Medicine at the Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, and holds dual appointments as Principal Investigator at NHS Blood and Transplant (NHSBT) and Consultant at NHSBT and Barts Health NHS Trust. Her clinical and research work focuses on evidence-based blood transfusion practices for acquired bleeding disorders across trauma, cardiac surgery, and obstetrics.

Her educational background includes:

• Specialist training in Haematology at King's College Hospital (2004)
• MD(Res) in Haemostasis and Thrombosis from University College London (2009-2011)

Professor Green's research centers on developing blood components and protocols for bleeding management, leading multi-centre national/international trials through the Transfusion Academic Unit. Her work bridges laboratory science and clinical practice to optimize transfusion strategies for major hemorrhage, with emphasis on trauma resuscitation, cardiac surgery coagulopathy, and obstetric emergencies.

Analysis of her publication record reveals consistent leadership in high-impact randomized controlled trials addressing critical gaps in transfusion medicine. Her studies demonstrate methodological rigor in evaluating blood components like cryoprecipitate and prothrombin complex concentrate, with findings directly influencing UK and international guidelines for trauma, postpartum haemorrhage, and cardiac surgery bleeding management.

She actively supervises doctoral candidates:

• Current students: Harriet Tucker (PhD, 2019-2024), Florence Oyekan (PhD, 2022-2026), Chibuzo Mowete (PhD, 2023-2027)
• Recent completions: Andrea Rossetto (PhD, 2024), Suzanne Forbes (MD, 2024), Josephine McCullagh (DClinSci, 2022), Ruchika Kohli (MD, 2021)

Professor Green leads the Transfusion Academic Unit, fostering integration between NHSBT laboratory services, Barts Health clinical teams, and Queen Mary research infrastructure to advance blood component innovation and evidence generation for bleeding disorders globally.